What causes yellow spots in the eyes and how are they treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yellow Spots in the Eyes: Causes and Treatment

Yellow spots in the eyes most commonly represent vitelliform lesions, subretinal deposits in central serous chorioretinopathy, or conjunctival pigmentation, with treatment ranging from observation to anti-VEGF injections depending on the underlying cause. 1

Primary Retinal Causes

Vitelliform Lesions

Best vitelliform macular dystrophy presents as yellowish subretinal lesions centered in the fovea, typically bilateral and symmetrical, with characteristic hyperautofluorescence on fundus autofluorescence imaging. 1

  • No treatment is available for most vitelliform dystrophies unless neovascularization develops, in which case intravitreal anti-VEGF injections are indicated 1
  • Adult-onset foveomacular vitelliform dystrophy shows small (<1 disc diameter) round foveal yellowish subretinal lesions, either unilateral or bilateral 1
  • Vitelliform lesions secondary to age-related macular degeneration require AREDS formula supplements, with anti-VEGF injections reserved for neovascularization 1

Central Serous Chorioretinopathy (CSC)

Yellow subretinal deposits occur in 65% of CSC cases, appearing as dot-like precipitates (≤63 μm) or larger subretinal yellow material (>63 μm). 2

  • These deposits show high reflectivity on OCT and hyperautofluorescence during follow-up, indicating photoreceptor outer segment shedding and phagocytic metabolism 2
  • Treatment depends on CSC chronicity and presence of complications; photodynamic therapy or anti-VEGF injections may be indicated for chronic cases with neovascularization 1

Acute Exudative Polymorphous Vitelliform Maculopathy

Multiple, bilateral well-defined serous macular detachments with subretinal accumulation of yellow-white material characterize this condition. 1

  • Shows hyperautofluorescence on FAF with no focal leakage on fluorescein angiography 1
  • No treatment is available for this self-limited condition 1

Inflammatory Causes

White Dot Syndromes

Rapid onset with progressive vision loss, featuring placoid subretinal yellow-white lesions on fundoscopy and OCT. 1

  • Local and/or oral corticosteroids are first-line treatment, with systemic immunosuppressive medication for severe cases 1
  • Anti-VEGF injections are reserved for cases developing neovascularization 1

Vogt-Koyanagi-Harada Disease

Bilateral in 95% of cases with rapid onset in young patients, showing numerous central leakage points on fluorescein angiography. 1

  • Corticosteroids and systemic immunosuppressive medication are the mainstay of treatment 1

Ocular Syphilis

Pale yellowish perivascular preretinal dots represent a manifestation of ocular syphilis, likely due to perivasculitis from treponema infection. 3

  • IV crystalline penicillin for 14 days is the definitive treatment 3
  • Consider this diagnosis in patients with panuveitis and risk factors for sexually transmitted infections 3

Corneal and Conjunctival Causes

Peripheral Yellow Corneal Rings

Circumferential yellow peripheral corneal rings can develop from vitamin supplementation for age-related macular degeneration, particularly AREDS formulations. 4

  • Associated with subtle yellowing of skin, most notable on palms 4
  • Serum carotene levels may be normal or elevated 4
  • These rings are benign but may be misdiagnosed as arcus senilis 4

Conjunctival Pigmentation

Conjunctival melanoma presents as painless, flat or nodular brown lesions on the bulbar or palpebral conjunctiva. 5

  • Urgent ophthalmology referral is required for enlargement, development of blood vessels, or thickening of pigmented lesions 5
  • Melanoma can metastasize and threaten life if not promptly treated 5

Critical Differential Diagnoses

Neovascular Disease

Polypoidal choroidal vasculopathy shows polypoidal dilatations on OCT and ICGA in older patients. 1

  • Treatment includes intravitreal anti-VEGF injections and/or photodynamic therapy 1

Pachychoroid neovasculopathy presents with neovascular networks over areas of choroidal thickening. 1

  • Requires intravitreal anti-VEGF injections and/or photodynamic therapy 1

Ocular Tumors

Choroidal melanoma appears as hyperpigmented (sometimes amelanotic) elevated choroidal mass with multiple pinpoint leakage areas on fluorescein angiography. 1

  • Treatment options include brachytherapy, proton therapy, or enucleation based on staging 1

Diagnostic Approach

Slit-lamp biomicroscopy is essential to evaluate the location and depth of pigmentation and associated findings. 5

  • Optical coherence tomography differentiates subretinal from intraretinal deposits 2
  • Fundus autofluorescence identifies metabolically active lesions 1, 2
  • Fluorescein and indocyanine green angiography distinguish vascular from non-vascular causes 1

Key Clinical Pitfalls

  • Do not dismiss recurrent pigmented lesions in the same location, especially in elderly patients, as this raises suspicion for sebaceous carcinoma or melanoma 5, 6
  • Yellow corneal rings from vitamin supplementation are benign and should not prompt discontinuation of AREDS formulations without ophthalmology consultation 4
  • Preretinal yellowish dots in ocular syphilis are commonly overlooked but represent an important diagnostic clue 3
  • Vitelliform lesions require differentiation from neovascular disease, as treatment strategies differ dramatically 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Yellowish dots in the retina: a finding of ocular syphilis?

Arquivos brasileiros de oftalmologia, 2014

Guideline

Causes of Brown Discoloration of the Eye

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chalazion and Hordeolum Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.